Traditional marketing in healthcare feels a bit like shouting into a void. You spend months crafting campaigns, generating leads, and crossing your fingers, only to realize most of them aren’t even decision-makers. Sound familiar? That’s exactly why top Health tech companies are shifting to account-based marketing (ABM). 

Instead of marketing to the masses, they’re turning to a strategy that’s laser-focused, highly personalized, and built for today’s complex buying committees. After speaking with over 1,000 CIOs, CISOs, and healthcare executives throughout my career, one thing’s clear: the old way is out, and ABM is the smarter way forward. Let’s dive into why this shift is happening and why it matters more than ever in 2025.

Why Account-based Marketing Is Built for Health Tech’s Complexity

Healthcare buying cycles are unlike any other. A single deal may involve 6–10 stakeholders, from compliance to clinical leadership to IT security. A recent Gartner study confirmed that the average B2B buying group now includes 11 decision-makers. In healthcare? Sometimes more.

Instead of running generic campaigns, account-based marketing zeroes in on the specific pain points of individual decision-makers at named accounts. Think: tailored whitepapers for CIOs, ROI briefs for CFOs, and cybersecurity roadmaps for CISOs, all within the same account.

Companies that implement account-based marketing see, on average, a 76% increase in ROI compared to traditional methods. When the buying process is long and layered, as it is in healthcare, that ROI boost is impossible to ignore.

1. The R1 Perfect Match for Healthcare Dynamics 

Healthcare sales cycles often exceed 13 months and can stretch past 24 months. Each sale involves multiple stakeholders: CIOs, clinical leads, procurement, finance, compliance, you name it. ABM thrives here because it targets precisely those key accounts and messages. You’re not casting a wide net. You’re having the right conversation with the right people, at the right clip.

Take a HIMSS‑sponsored study: 86% of buyers rely heavily on demos, peer content, and executive briefs. That demands personalization, and ABM delivers it, with tailored content across the buying committee.

2. Industry Shift: From Curious to Committed

Today, real account-based marketing adoption is happening. Healthlaunchpad surveyed 40 HealthTech marketing leaders and found that while many are exploring, about one‑third are actively investing in ABM platforms and initiatives. 

This is no small fad. With growing adoption, health‑system marketers realize that ABM reaches high‑value targets more effectively than mass outreach and delivers better ROI with less waste.

3. Structured Approaches

Do you remember the anecdote: “It was less expensive than a bus”? Referring to early‑stage ABM pilots. HealthTech firms often start small: identify 5–10 high‑value target accounts, pilot ABM for 120 days, track meetings and ROI, then scale.

4. Multiple ABM Models

ABM isn’t one‑size‑fits‑all. According to HealthLaunchpad, three key models exist. A HealthTech pioneer, Nuvolo, used a one‑to‑one model: they built account‑branded pages, analyzed intent data, and aligned sales‑marketing cadences. Results: improved engagement and stronger decision‑maker alignment. 

One‑to‑Many: Standardized messages to a broader account list (e.g., 50–100 hospitals). Efficient at scale.

One‑to‑Few: Personalized outreach to a select group (10–20 accounts). Higher impact.

One‑to‑One: Fully custom engagements for ultra‑high‑value accounts (5–10), with bespoke landing pages, events, and executive briefings.

5. Integrating Intent Data & Timing

Timing matters. Healthcare organizations align purchases with fiscal years, tech refresh cycles, and policy changes. ABM tools like Terminus, Demandbase, and 6Sense tap real‑time signals to indicate when accounts are ripe. 

Behavioral data site visits, demo downloads trigger personalized outreach. That means higher relevance, fewer wasted touches, and shorter deal velocity.

6. Sales & Marketing: From Silos to Dream Team

ABM lifts the curtain between sales and marketing.  We’re talking joint pipeline reviews, shared dashboards, and integrated ABM tech stacks. This cohesion is key; abandon it, and your ABM program will sputter.

7. Measurable ROI: Because Data Matters

Why do so many marketers say ABM outperforms traditional efforts? In one HubSpot‑cited stat, 87% of ABM programs beat other strategies. Another says ABM yields 76% higher ROI, with 60% higher conversion rates.

Let’s break it down:

  • Better engagement, multiple touches across channels.
  • More pipelines from high‑value targets.
  • Shorter closing time thanks to precise timing.
  • Clear attribution, you know which account actions led to ROI.

8. Case Study: Caregility

When Caregility launched its ABM journey in 2020, it targeted large IDNs with multiple stakeholder personas. They used intent data, custom-branded pages, and coordinated outreach. The result? Better alignment, increased stakeholder engagement, and faster pipeline hand‑offs. 

Nuvolo and KeyOps used similar playbooks targeted at accounts, phased execution, and intentional team alignment, and saw measurable impact over 12–18 months.

9. Trends Accelerating ABM Maturity

Three trends are turbocharging ABM’s rise:

Unbundled ABM stacks: Marketers mix best‑in‑class tools, intent, analytics, and personalization rather than monolithic platforms. 

AI‑driven insights: These tools surface accounts ready to buy based on behavior, content consumption, and technographic data.

Privacy‑first compliance: Healthcare marketers are balancing personalization with HIPAA and privacy compliance using secure, consent‑based cookies and data usage practices. These allow high personalization with low risk.

10. Getting Started: Expert Tips for 2025

If you’re a CMO, VP, or HealthTech leader, here’s a pragmatic roadmap:

  • Start small: Choose 5–15 accounts, run a 90‑120‑day pilot with clear KPIs (meetings, pipeline, engagement).
  • Map your ICP: Use technographic, intent, and firmographic criteria. Collaborate with sales on the target list.
  • Produce tailored content: Personalize the experience via executive insight briefs, account‑centric landing pages, and case studies.
  • Track real‑time signals: Implement intent tools to trigger outreach at the most receptive moments.
  • Measure and iterate: Analyze early wins, test formats, refine personas, and scale smartly.

Why Shift to ABM Matters Now

Are you ready to follow? The answer is a resounding “yes”. With ABM, HealthTech firms can:

  • Engage high-value accounts with laser focus.
  • Shorten campaign timelines through intent-driven timing.
  • Increase ROI via a measurable, quality pipeline.
  • Strengthen alignment between sales and marketing.
  • Prepare for future AI- and data-driven sophistication.

From Broad Reach to Deep Impact

We’re at a tipping point in HealthTech marketing where scale no longer beats strategy, and where personalization isn’t a “nice-to-have,” it’s the price of entry. As this list shows, ABM isn’t reserved for the Fortune 500 or early adopters anymore. It’s becoming the standard for HealthTech companies that want to drive meaningful engagement and enterprise-level growth.

The companies leaning into ABM, whether they’re global pharma brands or strategic growth partners like Intent Amplify, are doing more than just generating leads. They’re building trust, shortening sales cycles, and creating experiences that resonate with every stakeholder, from CMIOs to procurement chiefs.

If you’re in HealthTech and still relying on spray-and-pray marketing tactics, it’s time to ask: Are you chasing attention, or earning it? ABM doesn’t just help you stand out. It helps you connect with the right people, at the right moment, in a way that drives real business results.

The future of B2B in healthcare is precise, personal, and powered by ABM. So, what’s your next move?

FAQs

1. I’m in HealthTech marketing, how do I know if ABM is right for my organization?

If your sales cycles are long, involve multiple decision-makers, and your product or service requires a high level of trust or education, ABM is likely a great fit. 

2. Does ABM only work for large companies with big marketing budgets?

Not at all. ABM is highly scalable. While enterprise players like Johnson & Johnson and Philips run broad ABM programs, smaller or mid-sized HealthTech firms can start with a “one-to-few” or “one-to-one” approach targeting just a handful of high-priority accounts.

3. How does ABM improve sales and marketing alignment?

ABM naturally brings sales and marketing teams together around shared goals. Instead of marketing chasing MQLs and sales chasing quotas, both teams align on account-level outcomes like meetings booked, engagement levels, and pipeline influenced. 

4. What’s one mistake HealthTech companies often make when starting with ABM?

One common pitfall is jumping straight into tools and tactics without clearly defining your ideal customer profile (ICP) or target accounts. ABM isn’t just about sending better emails; it’s about strategic focus. 

5. What’s one underrated factor that makes an ABM program truly successful in the HealthTech space?

One often overlooked success factor is cross-functional collaboration beyond sales and marketing. In health tech, involving compliance, product, and even clinical subject matter experts early in the ABM planning process can make campaigns more credible and relevant.

Dive deeper into the future of healthcare.

Keep reading on Health Technology Insights.

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com